Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression

  1. Santosh A. Helekar* and
  2. Jim Patrick
  1. Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030

Abstract

The functional expression of homo-oligomeric α7 neuronal nicotinic and type 3 serotonin receptors is dependent on the activity of a cyclophilin. In this paper we demonstrate that the mechanism of cyclophilin action during functional homo-oligomeric receptor expression in Xenopus oocytes is distinct from the calcineurin-dependent immunosuppressive mechanism by showing that a nonimmunosuppressive analog of cyclosporin A (CsA), SDZ 211–811, reduces functional receptor expression to the same extent as CsA. The cytoplasmic subtype of cyclophilin, cyclophilin A (CyPA), appears to be required for functional receptor expression. This is because overexpression of CyPA and a CyPA mutant that is deficient in CsA binding activity reverses CsA-induced reduction in functional receptor expression. The mechanism of action of CyPA is likely to involve its prolyl isomerase activity because a mutant CyPA with a single amino acid substitution (arginine 55 to alanine) that is predicted to produce a 1000-fold attenuation in isomerase activity fails to reverse the cyclosporin A effect. Our data also suggest that CyPA does not form a stable complex with receptor subunits.

Footnotes

  • * Present address: Department of Neurology, Baylor College of Medicine, Houston, TX 77030. e-mail: shelekar{at}bcm.tmc.edu.

  • Salih J. Wakil, Baylor College of Medicine, Houston, TX

  • ABBREVIATIONS:
    CsA,
    cyclosporin A;
    CyPA,
    cyclophilin A;
    CyPB,
    cyclophilin B;
    5HT3R,
    type 3 serotonin receptor;
    nAChR,
    nicotinic acetylcholine receptor;
    FKBP-12,
    12-kDa FK506-binding protein;
    PPIase,
    peptidyl prolyl isomerase;
    ER,
    endoplasmic recticulum
« Previous | Next Article »Table of Contents